Shares of Aurobindo Pharma rose as much as 2.18% in early morning trade after the company announced it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Ertapenem Injection 1 g/vial.
For Real Time News & Trading Trends Keep Liking Epic Research Private Limited
For more information on Equity Market News Call us ✆ – 0731-6642300 or Visit http://www.epicresearch.co
Connect with our social media sites
Follow @Epic_Research
No comments:
Post a Comment